Some features of beckman.com will be unavailable from 8:00 p.m. PDT Saturday, December 7 until 12:00 a.m. PDT, Sunday, December 8 for planned maintenance. During this time, you will not be able to log in to use account features such as online shopping, shopping lists and order tracking.
Please ensure your orders are processed prior to this maintenance period or contact Client Services for additional assistance.
Treatment for several autoimmune and allergen diseases can benefit considerably from immunotherapy. Allergen-specific immunotherapy is used clinically to desensitize the recruitment and activation of hyperreactive immune cells such as mast cells, eosinophils, and basophils. Recent immunotherapies targeting these cells focus on modulating key signaling molecules such as CTLA-4, TGF-β, histamine receptor 2, IL-10, and PD-1.1
Patients suffering from celiac disease are hyperreactive to gluten in the diet. Therapeutic vaccines are designed to introduce peptides containing immunodominant antigens for gluten-specific T cells. This is intended to disengage gluten-specific T cells from activating and has been shown to be safe in modulating immune responsiveness to gluten in recent trials.2
1. W. van de Veen, et al., "Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy," Curr Opin Immunol 48:74-81, 2017.
2. G. Goel, et al., "Epitope-specific immunotherapy targeting CD4-positive T cells in celiac disease: two randomized, double-blind, placebo-controlled phase 1 studies," Lancet Gastroenterol Hepatol 2(7):479-493, 2017.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.